Recently, the detection of the ERG protein, which is related to the presence of the fusion gene TMPRSS2-ERG, the most common and specific molecular alteration in prostate cancer, appears to be a complementary diagnostic argument in CUPs, since it is detected in approximately 30% of prostate metastases [61]. Here, ERG is linked to Familial prostate cancer.